Impact of the donor body mass index on the survival of pediatric liver transplant recipients and Post-transplant obesity

Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA.
Liver Transplantation (Impact Factor: 4.24). 08/2012; 18(8):930-9. DOI: 10.1002/lt.23438
Source: PubMed


In adult liver transplant recipients, the donor body mass index (dBMI) is associated with posttransplant obesity but not with graft or patient survival. Because of the obesity epidemic in the United States and the already limited supply of liver donors, clarifying whether the dBMI affects pediatric outcomes is important. United Network for Organ Sharing data for pediatric liver transplants in the United States (1990-2010) were evaluated. Data on transplants performed between 2004 and 2010 (n = 3788) were used for survival analyses with Kaplan-Meier and Cox proportional hazards models and for posttransplant obesity analyses with generalized estimating equations. For children receiving adult donor livers, a dBMI of 25 to <35 kg/m(2) was not associated with graft or patient survival in univariate or multivariate analyses. A dBMI ≥ 35 kg/m(2) increased the risk of graft loss [hazard ratio (HR) = 2.54, 95% confidence interval (CI) = 1.29-5.01, P = 0.007] and death (HR = 3.56, 95% CI = 1.64-7.72, P = 0.001). For pediatric donors, the dBMI was not associated with graft loss or mortality in a univariate or multivariate analysis. An overweight or obese donor was not a risk factor for posttransplant obesity. Overweight and obesity are common among liver transplant donors. This analysis suggests that for adult donors, a body mass index (BMI) of 25 to <35 kg/m(2) should not by itself be a contraindication to liver donation. Severe obesity (BMI ≥ 35 kg/m(2)) in adult donors increased the risk of graft loss and mortality, even after adjustments for recipient, donor, and transplant risk factors. Posttransplant obesity was not associated with the dBMI in this analysis. Further research is needed to clarify the impact of donor obesity on pediatric liver transplant recipients.

Download full-text


Available from: Philip Rosenthal, Jun 29, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: As the pressure for providing liver transplantation to more and more candidates increases, transplant programs have begun to consider deceased donor characteristics that were previously considered unacceptable. With this trend, attention has focused on better defining those donor factors that can impact the outcome of liver transplantation. This review examines deceased donor factors that have been associated with patient or graft survival as well as delayed graft function and other liver transplant results.
    Preview · Article · Feb 2013 · Transplant International
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Living donor liver transplantation (LDLT) is an accepted option for end-stage liver disease, particularly in countries in which there are organ shortages. However, little is known regarding LDLT for obese patients. We sought to determine the effects of obesity on pre-transplant living donor selection for obese recipients and their outcomes. Based on BMI values, 148 patients were classified as normal (N), 148 were overweight (OW), and 74 were obese (O). Obese recipients had significantly greater BMI values and received larger actual grafts than recipients with normal BMI values (32.1 ±1.6 kg/m(2) vs. 23.2 ± 1.9 kg/m(2) , p < 0.0001, and 918.9 ± 173.7 gm vs. 839.4 ± 162 gm, p = 0.002). Donors who donated to obese recipients had a greater mean BMI than those who donated to N recipients (26.3 ± 3.8 kg/m(2) for those who donated to O recipients vs. 24.4 ± 3.2 kg/m(2) for those who donated to N recipients; p=0.0001). Although obese recipients were more likely to face some challenges for finding a suitable living donor, there were no differences in graft and recipient survivals between the three groups in an adjusted Cox proportional hazards model (HR = 0.955, 95 % CI: 0.474-1.924, p = 0.897 for graft survival and HR = 0.901, 95 % CI: 0.555-1.463, p = 0.673 for patient survival). There were no significant differences in post-transplant complication rates between the three recipient groups or the morbidity rates for donors who donated to obese recipients compared to those who donated to overweight and normal recipients (p = 0.26). Therefore, we recommend that obese patients should undergo pre-transplant evaluations. If adequately evaluated and selected, they should be considered for LDLT. Liver Transpl , 2013. © 2013 AASLD.
    Full-text · Article · Mar 2014 · Liver Transplantation
  • [Show abstract] [Hide abstract]
    ABSTRACT: Reflective of the gross national shortage of organs available for transplantation, utilization of extended criteria donor livers has gained momentum, arguing the merits of transplantation with higher risk organs outweighs the risks associated with staying on the waiting list. As a result, high-risk extended criteria allografts, previously referred to as marginal or compromised organs, have become an important part of the donor organ supply. Unfortunately, the use of “expanded” criteria liver allografts remains undefined. Therefore, due to regional heterogeneity in the landscape of national scarcity, allocation policies for extended criteria allografts have largely been transplant center specific and calibrated based on predicted recipient benefit, projected reduction in waitlist mortality, and parity. The utility, selection, and performance of “extended criteria” donor allograft livers are examined in this review.
    No preview · Article · Sep 2015